Nicolas Mach
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Mast cells and histamine
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
- Oncology 39
- Cancer Immunotherapy and Biomarkers 20
- CAR-T cell therapy research 16
- Immunology 25
- Immunotherapy and Immune Responses 22
- Immune Cell Function and Interaction 8
- Co-authors
- Glenn Dranoff (8 shared papers)Silke Gillessen (4 shared papers)Martín C. Mihm (3 shared papers)S. Brian Wilson (2 shared papers)C. Sheehan (1 shared paper)Richard C. Mulligan (3 shared papers)Stephen J. Galli (2 shared papers)Chris S. Lantz (2 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (12 papers)Blood (4 papers)Vaccines (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Nicolas Mach
96 papers receiving 3.1k citations
Nicolas Mach's Hit Papers
Peers
Comparison fields: 5 of 122
- Immunology 1.5k
- Otorhinolaryngology 167
- Oncology 975
- Immunology and Allergy 163
- Infectious Diseases 257
Countries citing papers authored by Nicolas Mach
This map shows the geographic impact of Nicolas Mach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Mach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Mach more than expected).
Fields of papers citing papers by Nicolas Mach
This network shows the impact of papers produced by Nicolas Mach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Mach. The network helps show where Nicolas Mach may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Mach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 446 | |
| 2 | Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. | 2000 | 348 |
| 3 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 271 |
| 4 | 2007 | 196 | |
| 5 | 2021 | 138 | |
| 6 | 1990 | 96 | |
| 7 | 2014 | 94 | |
| 8 | 2000 | 92 | |
| 9 | 2020 | 87 | |
| 10 | 2003 | 85 | |
| 11 | 2005 | 84 | |
| 12 | 2003 | 75 | |
| 13 | Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. | 2001 | 73 |
| 14 | 2017 | 61 | |
| 15 | 1998 | 60 | |
| 16 | 2014 | 59 | |
| 17 | 2017 | 57 | |
| 18 | 2002 | 35 | |
| 19 | 2008 | 35 | |
| 20 | 2007 | 34 |
About Nicolas Mach
Nicolas Mach is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Otorhinolaryngology, having authored 99 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (22 papers), Cancer Immunotherapy and Biomarkers (20 papers), CAR-T cell therapy research (16 papers), Head and Neck Cancer Studies (13 papers), Lung Cancer Treatments and Mutations (11 papers), Immune Cell Function and Interaction (8 papers), Virus-based gene therapy research (7 papers) and Cancer Research and Treatments (7 papers). The work is most often cited by research in Immunology (1.5k citations), Otorhinolaryngology (167 citations), Oncology (975 citations), Immunology and Allergy (163 citations) and Infectious Diseases (257 citations). Nicolas Mach has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Glenn Dranoff, Silke Gillessen, Martín C. Mihm, S. Brian Wilson, C. Sheehan, Richard C. Mulligan, Stephen J. Galli, Chris S. Lantz, Yukifumi Nawa and Takahiko Kobayashi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, Vaccines and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.